Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-30

FDA Approved: YESINTEK — Original Application (Biocon Biologics Inc.)

View source ↗

Summary

The FDA approved Yesintek (ustekinumab) from Biocon Biologics Inc. under an original Biologics License Application. It is indicated for plaque psoriasis, psoria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YESINTEK (USTEKINUMAB)

Snippet

ORIG AP for YESINTEK (USTEKINUMAB)